All India Institute of Medical Sciences, Bhubaneswar
aiimsbhubaneswar.nic.inTotal trials
53
Active
15
Phase 3
2
Total enrollment
4,071
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 13 of 13 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Aripiprazole | — | — | — | — | — | 2 | |
| Hyaluronic Acid | — | — | — | — | — | 1 | |
| Mitomycin -C | — | — | — | — | — | 1 | |
| Tofacitinib 5 mg BID and Triamcinolone ointment | — | — | — | — | — | 1 | |
| Dosulepin | — | — | — | — | 2 | ||
| Venlafaxine | — | — | — | — | 2 | ||
| Steroid | — | — | — | — | — | 1 | |
| Antibiotic | — | — | — | — | — | 1 | |
| RhizomK | — | — | — | — | — | 1 | |
| Atenolol 25 mg | — | — | — | — | — | 1 | |
| Ivabradine 10mg | — | — | — | — | — | 1 | |
| Prosman | — | — | — | — | — | 1 | |
| Selenium | — | — | — | — | — | 1 |
Next readouts
- 2025-06-30
- 2025-08-05
- 2025-10-31
- 2026-05-30
- 2026-08
- 2026-10
- 2027-01-01
- 2027-04-04
- 2027-10-30
Top conditions
- Schizophrenia5
- Treatment Resistant Schizophrenia3
- Morbid Obesity2
- Non-Alcoholic Fatty Liver Disease2
- Major Depressive Disorder2
- Perforated Bowel2
- Post-Op Complication2
- Emergencies2
Frequently asked questions about All India Institute of Medical Sciences, Bhubaneswar
- How many clinical trials does All India Institute of Medical Sciences, Bhubaneswar have on ClinicalTrials.gov?
- All India Institute of Medical Sciences, Bhubaneswar is listed as the lead sponsor on 53 clinical trials in ClinicalTrials.gov, 15 of which are currently active (recruiting, enrolling, or ongoing).
- How many of All India Institute of Medical Sciences, Bhubaneswar's trials are in Phase 3?
- 2 of All India Institute of Medical Sciences, Bhubaneswar's trials are in Phase 3, spread across 13 active drug programs.
- What therapeutic areas does All India Institute of Medical Sciences, Bhubaneswar focus on?
- All India Institute of Medical Sciences, Bhubaneswar's most-studied conditions on ClinicalTrials.gov are Schizophrenia, Treatment Resistant Schizophrenia, Morbid Obesity, Non-Alcoholic Fatty Liver Disease, Major Depressive Disorder.
- When are All India Institute of Medical Sciences, Bhubaneswar's next clinical trial readouts?
- All India Institute of Medical Sciences, Bhubaneswar has 9 upcoming primary-completion readouts tracked here; the soonest is “Effect of Atenolol Versus Ivabradine on HRV in TRS Patients on Clozapine With Tachycardia: A Randomised Control Trial.”, expected around 2025-06-30.